Shares of Sun Pharmaceutical Industries declined by 2.29% to Rs 1,618.70 in Tuesday's early trading session. A Moneycontrol analysis as of August 21, 2025 reflects a bearish sentiment on Sun Pharma stock.
Financial Highlights
Sun Pharmaceutical Industries' financial performance shows consistent growth in revenue and net profit over the past few years. The consolidated revenue for the year ending March 2025 stood at Rs 52,578.44 Crore, compared to Rs 48,496.85 Crore for the year ending March 2024. Net profit also increased from Rs 9,648.44 Crore in March 2024 to Rs 10,980.10 Crore in March 2025.
The quarterly performance also reveals a positive trend. Revenue for the quarter ending June 2025 was Rs 13,851.40 Crore, up from Rs 12,652.75 Crore in June 2024. The net profit for the same period was Rs 2,302.62 Crore, slightly down from Rs 2,871.25 Crore in June 2024.
Key financial data is summarized below:
| Financial Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) | BVPS (Rs) | ROE (%) | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | 33,498.14 | 2,284.68 | 12.10 | 206.23 | 6.24 | 0.07 |
| 2022 | 38,654.49 | 3,405.82 | 13.60 | 212.84 | 6.81 | 0.02 |
| 2023 | 43,885.68 | 8,560.84 | 35.30 | 247.22 | 15.13 | 0.11 |
| 2024 | 48,496.85 | 9,648.44 | 39.90 | 265.36 | 15.04 | 0.04 |
| 2025 | 52,578.44 | 10,980.10 | 45.60 | 301.00 | 15.13 | 0.03 |
Sun Pharmaceutical Industries has demonstrated consistent growth in key financial metrics from 2021 to 2025. Revenue increased from Rs 33,498.14 Crore in 2021 to Rs 52,578.44 Crore in 2025. Net profit also saw a substantial rise, from Rs 2,284.68 Crore in 2021 to Rs 10,980.10 Crore in 2025. Earnings per share (EPS) have increased from Rs 12.10 in 2021 to Rs 45.60 in 2025, and the book value per share (BVPS) has grown from Rs 206.23 to Rs 301.00 over the same period. The company's Return on Equity (ROE) has remained relatively stable at around 15% in recent years, and the debt-to-equity ratio has been maintained at a low level, indicating a strong financial position.
Quarterly Performance
| Quarter | Sales (Rs Crore) | Other Income (Rs Crore) | Total Income (Rs Crore) | Total Expenditure (Rs Crore) | EBIT (Rs Crore) | Interest (Rs Crore) | Tax (Rs Crore) | Net Profit (Rs Crore) |
|---|---|---|---|---|---|---|---|---|
| Jun 2025 | 13,851 | 464 | 14,315 | 11,068 | 3,247 | 74 | 870 | 2,302 |
| Mar 2025 | 12,958 | 612 | 13,571 | 10,268 | 3,303 | 49 | 1,093 | 2,160 |
| Dec 2024 | 13,675 | 465 | 14,141 | 10,613 | 3,527 | 51 | 558 | 2,917 |
| Sep 2024 | 13,291 | 354 | 13,645 | 9,978 | 3,667 | 69 | 567 | 3,030 |
| Jun 2024 | 12,652 | 532 | 13,185 | 9,700 | 3,485 | 61 | 552 | 2,871 |
The quarterly data shows revenue increasing from Rs 12,652 Crore in June 2024 to Rs 13,851 Crore in June 2025. Similarly, net profit varied across the quarters, with the highest being Rs 3,030 Crore in September 2024 and the lowest at Rs 2,160 Crore in March 2025. Total expenditure has generally remained stable, contributing to fluctuations in net profit.
Corporate Actions
Sun Pharmaceutical Industries has announced several corporate actions, including analyst/investor meetings. The company announced a final dividend of Rs 5.50 per share (550%) on May 22, 2025, which was effective from July 7, 2025. Additionally, an interim dividend of Rs 10.50 per share (1050%) was announced on January 16, 2025, effective from February 6, 2025.
The company has a history of bonus issues, including a 1:1 bonus on July 29, 2013, and another 1:1 bonus on May 27, 2004. A 2:1 bonus was issued on March 6, 2000.
Furthermore, Sun Pharmaceutical Industries has executed stock splits, including a split from a face value of Rs 5 to Rs 1 on November 25, 2010, and a split from Rs 10 to Rs 5 on January 13, 2003.
With the stock currently trading at Rs 1,618.70, Sun Pharmaceutical Industries reflects a bearish trend amid overall positive financial performance and active corporate actions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
